Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-047106
Filing Date
2025-03-28
Accepted
2025-03-28 20:59:21
Documents
1
Period of Report
2025-03-26

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 22636
  Complete submission text file 0000950170-25-047106.txt   24216
Mailing Address 1700 OWENS STREET SUITE 500 SAN FRANCISCO CA 94158
Business Address
Kutzkey Tim (Reporting) CIK: 0001614186 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39635 | Film No.: 25788433

Mailing Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-475-2820
Surrozen, Inc./DE (Issuer) CIK: 0001824893 (see all company filings)

EIN.: 301374889 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)